Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share (NAUT)

Historical Holders from Q2 2021 to Q3 2025

Symbol
NAUT on Nasdaq
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
126,882,307
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
57,898,961
Holdings value
$48,912,478
% of all portfolios
0%
Number of holders
64
Number of buys
16
Number of sells
-38
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share (NAUT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Mallick Parag 17% $15,807,377 22,263,911 Parag Mallick 03 Mar 2025
Patel Sujal M 16% $14,411,390 20,297,732 Sujal Patel 03 Mar 2025
PERCEPTIVE ADVISORS LLC 10% +1% $11,149,148 +$192,185 12,815,113 +1.8% Perceptive Advisors LLC 20 Jun 2025

Institutional Holders of Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share (NAUT)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 57,898,961 $48,912,478 -$1,403,087 $0.8449 64
2025 Q2 59,755,012 $43,314,600 -$2,449,905 $0.7249 67
2025 Q1 62,775,437 $54,045,644 -$1,026,756 $0.8610 86
2024 Q4 63,869,661 $107,299,374 -$821,201 $1.68 86
2024 Q3 64,190,100 $182,943,834 +$1,290,455 $2.85 81
2024 Q2 63,999,578 $149,759,950 +$1,608,547 $2.34 75
2024 Q1 63,240,413 $185,925,873 -$499,885 $2.94 70
2023 Q4 63,424,716 $189,647,655 +$5,847,645 $2.99 74
2023 Q3 45,082,721 $142,463,072 +$769,963 $3.16 74
2023 Q2 44,814,450 $173,427,573 +$1,498,150 $3.87 74
2023 Q1 44,499,314 $123,255,982 -$1,802,223 $2.77 72
2022 Q4 46,081,461 $82,942,228 -$2,657,044 $1.80 78
2022 Q3 56,460,432 $119,696,429 -$2,490,160 $2.12 77
2022 Q2 57,502,356 $154,669,821 +$297,442 $2.69 80
2022 Q1 56,024,124 $243,509,430 -$20,551,922 $4.34 79
2021 Q4 41,913,282 $217,115,889 +$1,259,255 $5.18 77
2021 Q3 40,974,903 $245,092,558 +$9,814,243 $6.14 68
2021 Q2 33,010,619 $331,901,744 +$331,901,478 $10.10 55